Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Vector characterization methods for quality control testing of recombinant adeno-associated virusesJ Fraser Wright, Olga ZelenaiaNeuropharmacology|September 27, 2005
Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1Elizabeth Krizman-Genda, Marco I González, Olga Zelenaia, et al.Journal of Neurochemistry|April 1, 2006
Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtypeLi-Bin Li, Shuy Vang Toan, Olga Zelenaia, et al.Journal of Neurochemistry|December 1, 2004
Differential regulation of GLAST immunoreactivity and activity by protein kinase C: evidence for modification of amino and carboxyl terminiBala T S Susarla, Rebecca P Seal, Olga Zelenaia, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2008
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responsesBernd Hauck, Samuel L Murphy, Peter H Smith, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2008
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transferJeannette Bennicelli, John Fraser Wright, Andras Komaromy, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 28, 2012
Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate modelDavid A Suhy, Shih-Chu Kao, Tin Mao, et al.The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.The New England Journal of Medicine|April 29, 2008
Safety and efficacy of gene transfer for Leber's congenital amaurosisAlbert M Maguire, Francesca Simonelli, Eric A Pierce, et al.Lancet (London, England)|October 27, 2009
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trialAlbert M Maguire, Katherine A High, Alberto Auricchio, et al.Pageof 2